Cover Image
Market Research Report
Product code 
1078278

Corneal Implants Market Size By Tissue Type, By Transplant Type, By Condition, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028

Published: | Global Market Insights Inc. | 117 Pages | Delivery time: 2-3 business days

Price

Back to Top
Corneal Implants Market Size By Tissue Type, By Transplant Type, By Condition, By End-use, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2022 - 2028
Published: April 26, 2022
Global Market Insights Inc.
Content info: 117 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The corneal implants market is expected to grow significantly by 2028 owing to surging advancements in corneal implant technology. In addition, increasing investment towards R&D activities in corneal implants would further propel market growth through the forecast timeframe.

According to the World Health Organization (WHO), at least 2.2 billion people suffer from some type of vision impairment caused by glaucoma and corneal opacity, among other reasons. Corneal implants are surgeries that replace damaged cornea tissues with healthy donor tissues. Notably, during the coronavirus outbreak, the market witnessed a setback due to a halt in non-essential surgeries. However, corneal implants gained popularity as an effective option for corneal ectasis, boosting market growth during the pandemic.

Moreover, industry players have been adopting collaborative strategies and investing in product innovation to improve their standing in the corneal implants market, which has been favorable for the overall business scenario. For instance, in October 2021, CorNeat, a leading player in the industry, received a 2.5 million EURO grant for their CorNeat KPro, the firm's artificial cornea project, from the European Innovation Council (EIC). The project has proven to completely rehabilitate vison in blind people.

In another instance, in February 2022, a group of researchers from the University of Sydney and the University of South Wales announced successful bionic implant tech results through an analytical technology, Phoenix99. The novel tech is connected wirelessly to a pair of glasses and functions by stimulating the user's retina.

The corneal implants market has been bifurcated based on transplant, tissue type, condition, end-use, and region. In terms of tissue type, the market has been divided into artificial cornea and human donor. The artificial cornea segment is estimated to expand at a CAGR of over 8% through the assessment timeframe due to rising demand for artificial cornea.

Based on transplant, the market has been further categorized into endothelial lamellar keratoplasty, anterior lamellar keratoplasty, penetrating keratoplasty, and others. The anterior lamellar keratoplasty segment was valued at around USD 11 million in 2021. The involvement of low intraoperative complications as compared to open sky procedures is expected to propel segmental growth.

With regards to condition, the corneal implants market has been segregated into Fuchs' dystrophy, keratoconus, fungal keratitis, and others. The Fuchs' dystrophy segment held around 53% market share in 2021 and is projected to observe solid growth through 2028. The segmental expansion is positively impacted by mounting incidences of the disease, coupled with growing awareness among the global population pertaining to the illness.

In terms of end-use, the market has been split into eye clinics, hospitals, and ambulatory surgical centers. The ambulatory surgical centers segment held more than USD 133 million in revenue in 2021 and is forecast to grow substantially over 2022-2028 due to soaring availability of trained professionals and cost-effective treatment.

In the regional landscape, the Latin America corneal implants market accounts for a sizable share in the overall industry revenue and is set to witness robust growth at approximately 6% CAGR by 2028.

Product Code: 1227

Table of Contents

Chapter 1 Methodology

  • 1.1 Methodology
  • 1.2 Market definitions
  • 1.3 Forecast parameters
  • 1.4 Data sources
    • 1.4.1 Secondary
      • 1.4.1.1 Paid sources
      • 1.4.1.2 Unpaid sources
    • 1.4.2 Primary

Chapter 2 Executive Summary

  • 2.1 Corneal implants industry 360 degree synopsis, 2017 - 2028
    • 2.1.1 Business trends
    • 2.1.2 Tissue type trends
    • 2.1.3 Transplant type trends
    • 2.1.4 Condition trends
    • 2.1.5 End-use trends
    • 2.1.6 Regional trends

Chapter 3 Corneal Implants Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing incidence of eye diseases worldwide
      • 3.3.1.2 Rising elderly population in developed economies
      • 3.3.1.3 Growing demand for minimally invasive surgical procedure across the globe
      • 3.3.1.4 Increasing technological advancements in corneal implants
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Risks associated with corneal implants
      • 3.3.2.2 Shortage of donor material worldwide
  • 3.4 Growth potential analysis
    • 3.4.1 By tissue type
    • 3.4.2 By transplant type
    • 3.4.3 By condition
    • 3.4.4 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Corneal Implants Market, By Tissue Type

  • 4.1 Key segment trends
  • 4.2 Human donor
    • 4.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 4.3 Artificial cornea
    • 4.3.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 5 Corneal Implants Market, By Transplant Type

  • 5.1 Key segment trends
  • 5.2 Anterior lamellar keratoplasty
    • 5.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.3 Endothelial lamellar keratoplasty
    • 5.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.4 Penetrating keratoplasty
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Corneal Implants Market, By Condition

  • 6.1 Key segment trends
  • 6.2 Fungal keratitis
    • 6.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.3 Fuchs' dystrophy
    • 6.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.4 Keratoconus
    • 6.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 6.5 Others
    • 6.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 7 Corneal Implants Market, By End-use

  • 7.1 Key segment trends
  • 7.2 Hospitals
    • 7.2.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.3 Eye clinics
    • 7.3.1 Market size, by region, 2017 - 2028 (USD Million)
  • 7.4 Ambulatory surgical centers
    • 7.4.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 8 Corneal Implants Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.2.2 Market size, by tissue type, 2017 - 2028 (USD Million)
    • 8.2.3 Market size, by transplant type, 2017 - 2028 (USD Million)
    • 8.2.4 Market size, by condition, 2017 - 2028 (USD Million)
    • 8.2.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.2.6 U.S.
      • 8.2.6.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.2.6.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.2.6.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.2.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.2.7 Canada
      • 8.2.7.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.2.7.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.2.7.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.2.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by tissue type, 2017 - 2028 (USD Million)
    • 8.3.2 Market size, by transplant type, 2017 - 2028 (USD Million)
    • 8.3.3 Market size, by condition, 2017 - 2028 (USD Million)
    • 8.3.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.5 Germany
      • 8.3.5.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.3.5.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.3.5.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.3.5.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.6 UK
      • 8.3.6.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.3.6.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.3.6.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.3.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.7 France
      • 8.3.7.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.3.7.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.3.7.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.3.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.8 Spain
      • 8.3.8.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.3.8.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.3.8.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.3.8.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.3.9 Italy
      • 8.3.9.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.3.9.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.3.9.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.3.9.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.4.2 Market size, by tissue type, 2017 - 2028 (USD Million)
    • 8.4.3 Market size, by transplant type, 2017 - 2028 (USD Million)
    • 8.4.4 Market size, by condition, 2017 - 2028 (USD Million)
    • 8.4.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.6 Japan
      • 8.4.6.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.4.6.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.4.6.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.4.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.7 China
      • 8.4.7.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.4.7.2 Market size, by transplant Type, 2017 - 2028 (USD Million)
      • 8.4.7.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.4.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.8 India
      • 8.4.8.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.4.8.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.4.8.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.4.8.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.9 South Korea
      • 8.4.9.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.4.9.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.4.9.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.4.9.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.4.10 Australia
      • 8.4.10.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.4.10.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.4.10.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.4.10.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.5.2 Market size, by tissue type, 2017 - 2028 (USD Million)
    • 8.5.3 Market size, by transplant type, 2017 - 2028 (USD Million)
    • 8.5.4 Market size, by condition, 2017 - 2028 (USD Million)
    • 8.5.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.5.6.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.5.6.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.5.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.7 Mexico
      • 8.5.7.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.5.7.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.5.7.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.5.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.5.8 Argentina
      • 8.5.8.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.5.8.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.5.8.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.5.8.4 Market size, by end-use, 2017 - 2028 (USD Million)
  • 8.6 MEA
    • 8.6.1 Market size, by country, 2017 - 2028 (USD Million)
    • 8.6.2 Market size, by tissue type, 2017 - 2028 (USD Million)
    • 8.6.3 Market size, by transplant type, 2017 - 2028 (USD Million)
    • 8.6.4 Market size, by condition, 2017 - 2028 (USD Million)
    • 8.6.5 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.6 South Africa
      • 8.6.6.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.6.6.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.6.6.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.6.6.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.7 Saudi Arabia
      • 8.6.7.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.6.7.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.6.7.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.6.7.4 Market size, by end-use, 2017 - 2028 (USD Million)
    • 8.6.8 UAE
      • 8.6.8.1 Market size, by tissue type, 2017 - 2028 (USD Million)
      • 8.6.8.2 Market size, by transplant type, 2017 - 2028 (USD Million)
      • 8.6.8.3 Market size, by condition, 2017 - 2028 (USD Million)
      • 8.6.8.4 Market size, by end-use, 2017 - 2028 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Strategy dashboard, 2021
  • 9.2 Alabama Eye Bank Inc.
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Alcon Inc.
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Florida Lions Eye Bank
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Presbia PLC
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 San Diego Eye Bank
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 CorNeat Vision Ltd.
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 Aurolab
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 DIPOTEX
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 AJL Ophthalmic SA
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 KeraMed, Inc.
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 Massachusetts Eye and Ear
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 MEDIPHACOS
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis
  • 9.14 MicroKpro
    • 9.14.1 Business overview
    • 9.14.2 Financial data
    • 9.14.3 Product landscape
    • 9.14.4 Strategic outlook
    • 9.14.5 SWOT analysis

Data Tables

  • TABLE 1 Corneal implants industry 360 degree synopsis, 2017 - 2028
  • TABLE 2 Corneal implants market, 2017 - 2028 (USD Million)
  • TABLE 3 Corneal implants market, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 4 Corneal implants, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 5 Corneal implants, by condition, 2017 - 2028 (USD Million)
  • TABLE 6 Corneal implants market, by end-use, 2017 - 2028 (USD Million)
  • TABLE 7 Corneal implants market, by region, 2017 - 2028 (USD Million)
  • TABLE 8 Industry impact forces
  • TABLE 9 Human donor market size, by region, 2017 - 2028 (USD Million)
  • TABLE 10 Artificial cornea market size, by region, 2017 - 2028 (USD Million)
  • TABLE 11 Anterior lamellar keratoplasty market size, by region, 2017 - 2028 (USD Million)
  • TABLE 12 Endothelial lamellar keratoplasty market size, by region, 2017 - 2028 (USD Million)
  • TABLE 13 Penetrating keratoplasty market size, by region, 2017 - 2028 (USD Million)
  • TABLE 14 Others market size, by region, 2017 - 2028 (USD Million)
  • TABLE 15 Fungal keratitis market size, by region, 2017 - 2028 (USD Million)
  • TABLE 16 Fuchs' dystrophy market size, by region, 2017 - 2028 (USD Million)
  • TABLE 17 Keratoconus market size, by region, 2017 - 2028 (USD Million)
  • TABLE 18 Others market size, by region, 2017 - 2028 (USD Million)
  • TABLE 19 Hospitals market size, by region, 2017 - 2028 (USD Million)
  • TABLE 20 Eye clinics market size, by region, 2017 - 2028 (USD Million)
  • TABLE 21 Ambulatory surgical centers market size, by region, 2017 - 2028 (USD Million)
  • TABLE 22 North America corneal implants size, by country, 2017 - 2028 (USD Million)
  • TABLE 23 North America corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 24 North America corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 25 North America corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 26 North America corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 27 U.S. corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 28 U.S. corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 29 U.S. corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 30 U.S. corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 31 Canada corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 32 Canada corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 33 Canada corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 34 Canada corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 35 Europe corneal implants size, by country, 2017 - 2028 (USD Million)
  • TABLE 36 Europe corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 37 Europe corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 38 Europe corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 39 Europe corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 40 Germany corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 41 Germany corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 42 Germany corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 43 Germany corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 44 UK corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 45 UK corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 46 UK corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 47 UK corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 48 France corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 49 France corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 50 France corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 51 France corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 52 Italy corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 53 Italy corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 54 Italy corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 55 Italy corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 56 Spain corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 57 Spain corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 58 Spain corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 59 Spain corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 60 Asia Pacific corneal implants size, by country, 2017 - 2028 (USD Million)
  • TABLE 61 Asia Pacific corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 62 Asia Pacific corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 63 Asia Pacific corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 64 Asia Pacific corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 65 China corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 66 China corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 67 China corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 68 China corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 69 India corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 70 India corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 71 India corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 72 India corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 73 Japan corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 74 Japan corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 75 Japan corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 76 Japan corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 77 Australia corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 78 Australia corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 79 Australia corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 80 Australia corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 81 South Korea corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 82 South Korea corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 83 South Korea corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 84 South Korea corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 85 Latin America corneal implants size, by country, 2017 - 2028 (USD Million)
  • TABLE 86 Latin America corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 87 Latin America corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 88 Latin America corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 89 Latin America corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 90 Brazil corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 91 Brazil corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 92 Brazil corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 93 Brazil corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 94 Mexico corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 95 Mexico corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 96 Mexico corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 97 Mexico corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 98 Argentina corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 99 Argentina corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 100 Argentina corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 101 Argentina corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 102 MEA corneal implants size, by country, 2017 - 2028 (USD Million)
  • TABLE 103 MEA corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 104 MEA corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 105 MEA corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 106 MEA corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 107 South Africa corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 108 South Africa corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 109 South Africa corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 110 South Africa corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 111 Saudi Arabia corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 112 Saudi Arabia corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 113 Saudi Arabia corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 114 Saudi Arabia corneal implants size, by end-use, 2017 - 2028 (USD Million)
  • TABLE 115 UAE corneal implants size, by tissue type, 2017 - 2028 (USD Million)
  • TABLE 116 UAE corneal implants size, by transplant type, 2017 - 2028 (USD Million)
  • TABLE 117 UAE corneal implants size, by condition, 2017 - 2028 (USD Million)
  • TABLE 118 UAE corneal implants size, by end-use, 2017 - 2028 (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global corneal implants market, 2017 - 2028 (USD Million)
  • FIG. 3 Growth potential analysis, by tissue type
  • FIG. 4 Growth potential analysis, by transplant type
  • FIG. 5 Growth potential analysis, by condition
  • FIG. 6 Growth potential analysis, by end-use
  • FIG. 7 Porter's analysis
  • FIG. 8 PESTEL analysis
  • FIG. 9 Key segment trends, by tissue type
  • FIG. 10 Key segment trends, by transplant type
  • FIG. 11 Key segment trends, by condition
  • FIG. 12 Key segment trends, by end-use
  • FIG. 13 Key regional trends
  • FIG. 14 Strategy dashboard, 2021